These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 10418711)

  • 21. Impact of histological subtype on survival of patients with surgically-treated stage IA2-IIB cervical cancer: adenocarcinoma versus squamous cell carcinoma.
    Mabuchi S; Okazawa M; Matsuo K; Kawano M; Suzuki O; Miyatake T; Enomoto T; Kamiura S; Ogawa K; Kimura T
    Gynecol Oncol; 2012 Oct; 127(1):114-20. PubMed ID: 22728518
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment results of high-dose-rate remote afterloading brachytherapy for cervical cancer and retrospective comparison of two regimens.
    Wong FC; Tung SY; Leung TW; Sze WK; Wong VY; Lui CM; Yuen KK; O SK
    Int J Radiat Oncol Biol Phys; 2003 Apr; 55(5):1254-64. PubMed ID: 12654435
    [TBL] [Abstract][Full Text] [Related]  

  • 23. ASTRO Research Fellowship: apoptosis as a predictor of tumor response to radiation in stage IB cervical carcinoma. American Society for Therapeutic Radiology and Oncology.
    Wheeler JA; Stephens LC; Tornos C; Eifel PJ; Ang KK; Milas L; Allen PK; Meyn RE
    Int J Radiat Oncol Biol Phys; 1995 Jul; 32(5):1487-93. PubMed ID: 7635794
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pretreatment proliferation parameters do not add predictive power to clinical factors in cervical cancer treated with definitive radiation therapy.
    Tsang RW; Juvet S; Pintilie M; Hill RP; Wong CS; Milosevic M; Chapman W; Levin W; Manchul LA; Fykes AW
    Clin Cancer Res; 2003 Oct; 9(12):4387-95. PubMed ID: 14555510
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison between conventional surgery and radiotherapy for FIGO stage I-II cervical carcinoma: a retrospective Japanese study.
    Yamashita H; Nakagawa K; Tago M; Shiraishi K; Nakamura N; Ohtomo K; Oda K; Nakagawa S; Yasugi T; Taketani Y
    Gynecol Oncol; 2005 Jun; 97(3):834-9. PubMed ID: 15894366
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epidermal growth factor receptor (EGFR) and vascular endothelial growth factor (VEGF) negatively affect overall survival in carcinoma of the cervix treated with radiotherapy.
    Gaffney DK; Haslam D; Tsodikov A; Hammond E; Seaman J; Holden J; Lee RJ; Zempolich K; Dodson M
    Int J Radiat Oncol Biol Phys; 2003 Jul; 56(4):922-8. PubMed ID: 12829126
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tumor apoptosis in cervical cancer: its role as a prognostic factor in 42 radiotherapy patients.
    Kim JY; Cho HY; Lee KC; Hwang YJ; Lee MH; Roberts SA; Kim CH
    Int J Cancer; 2001 Oct; 96(5):305-12. PubMed ID: 11582583
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tumour cell kinetics as a prognostic factor in squamous cell carcinoma of the cervix treated with radiotherapy.
    Gasińska A; Urbański K; Jakubowicz J; Klimek M; Biesaga B; Wilson GD
    Radiother Oncol; 1999 Jan; 50(1):77-84. PubMed ID: 10225560
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Radiation therapy for uterine cervix cancer: importance of evaluation of pre-treatment tumor size with MR imaging].
    Sasaoka M; Nomoto Y; Shoji K; Kobayashi S; Toyota S; Nakagawa T
    Nihon Igaku Hoshasen Gakkai Zasshi; 1997 Jul; 57(8):505-9. PubMed ID: 9267139
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Significance of tumor volume and corpus uteri invasion in cervical cancer patients treated by radiotherapy.
    Narayan K; Fisher R; Bernshaw D
    Int J Gynecol Cancer; 2006; 16(2):623-30. PubMed ID: 16681737
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stromal invasion of the cervix can be excluded from the criteria for using adjuvant radiotherapy following radical surgery for patients with cervical cancer.
    Shimada M; Kigawa J; Takahashi M; Minagawa Y; Okada M; Kanamori Y; Itamochi H; Oishi T; Iba T; Terakawa N
    Gynecol Oncol; 2004 Jun; 93(3):628-31. PubMed ID: 15196855
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Concurrent radiotherapy with paclitaxel/carboplatin chemotherapy as a definitive treatment for squamous cell carcinoma of the uterine cervix.
    Lee MY; Wu HG; Kim K; Ha SW; Kim JS; Kim IA; Lee HP
    Gynecol Oncol; 2007 Jan; 104(1):95-9. PubMed ID: 16996117
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Histopathologic prognostic factors in stage II and III squamous cell carcinoma of the uterine cervix. An evaluation of 91 patients treated primarily with radiation therapy.
    Crissman JD; Budhraja M; Aron BS; Cummings G
    Int J Gynecol Pathol; 1987; 6(2):97-103. PubMed ID: 3692673
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immature glandular features in squamous cell carcinoma of the uterine cervix as an independent indicator of resistance to radiotherapy.
    Okada S; Tsuda H; Ohmi K; Kasamatsu T; Yamada T; Tsunematsu R; Sumi M; Tokuuye K; Yoshikawa H; Hirohashi S
    Int J Gynecol Cancer; 2002; 12(3):277-85. PubMed ID: 12060449
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interim results of a randomized trial of mitomycin C as an adjunct to radical radiotherapy in the treatment of locally advanced squamous-cell carcinoma of the cervix.
    Roberts KB; Urdaneta N; Vera R; Vera A; Gutierrez E; Aguilar Y; Ott S; Medina I; Sempere P; Rockwell S; Sartorelli AC; Fischer DB; Fischer JJ
    Int J Cancer; 2000 Aug; 90(4):206-23. PubMed ID: 10993961
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mature results of a phase II trial of concomitant cisplatin/pelvic radiotherapy for locally advanced squamous cell carcinoma of the cervix.
    Fields AL; Anderson PS; Goldberg GL; Wadler S; Beitler J; Sood B; Runowicz CD
    Gynecol Oncol; 1996 Jun; 61(3):416-22. PubMed ID: 8641625
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The adverse effect of treatment prolongation in cervical cancer by high-dose-rate intracavitary brachytherapy.
    Chen SW; Liang JA; Yang SN; Ko HL; Lin FJ
    Radiother Oncol; 2003 Apr; 67(1):69-76. PubMed ID: 12758242
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Postoperative radiotherapy in early stage carcinoma of the uterine cervix: treatment results and prognostic factors.
    Yeh SA; Wan Leung S; Wang CJ; Chen HC
    Gynecol Oncol; 1999 Jan; 72(1):10-5. PubMed ID: 9889023
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cyclooxygenase-2 impairs treatment effects of radiotherapy for cervical cancer by inhibition of radiation-induced apoptosis.
    Ishikawa H; Ohno T; Kato S; Wakatsuki M; Iwakawa M; Ohta T; Imai T; Mitsuhashi N; Noda SE; Nakano T; Tsujii H
    Int J Radiat Oncol Biol Phys; 2006 Dec; 66(5):1347-55. PubMed ID: 16979845
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic value of cervical size and pelvic lymph node status assessed by computed tomography for patients with uterine cervical cancer treated by radical radiation therapy.
    Toita T; Nakano M; Higashi M; Sakumoto K; Kanazawa K
    Int J Radiat Oncol Biol Phys; 1995 Nov; 33(4):843-9. PubMed ID: 7591892
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.